Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Impact of triage-to-admission time on patient outcome in European intensive care units: A prospective, multi-national study.

Stohl S, Sprung CL, Lippert A, Pirracchio R, Artigas A, Iapichino G, Harris S, Pezzi A, Schlesinger M.

J Crit Care. 2019 Oct;53:11-17. doi: 10.1016/j.jcrc.2019.05.013. Epub 2019 May 29.

PMID:
31174171
2.

Donor characteristics and hematopoietic stem cell transplantation outcome: experience of a single center in Southern Brazil.

Paz A, Rigoni L, Fischer G, Schittler M, Pezzi A, Valim V, Dahmer A, Zambonato B, Amorin B, Sehn F, Silva MAD, Daudt L, Silla L.

Hematol Transfus Cell Ther. 2018 Apr-Jun;40(2):136-142. doi: 10.1016/j.htct.2017.11.008. Epub 2018 Feb 17.

3.

Intensive care unit patients with lower respiratory tract nosocomial infections: the ENIRRIs project.

De Pascale G, Ranzani OT, Nseir S, Chastre J, Welte T, Antonelli M, Navalesi P, Garofalo E, Bruni A, Coelho LM, Skoczynski S, Longhini F, Taccone FS, Grimaldi D, Salzer HJF, Lange C, Froes F, Artigas A, Díaz E, Vallés J, Rodríguez A, Panigada M, Comellini V, Fasano L, Soave PM, Spinazzola G, Luyt CE, Alvarez-Lerma F, Marin J, Masclans JR, Chiumello D, Pezzi A, Schultz M, Mohamed H, Van Der Eerden M, Hoek RAS, Gommers DAMPJ, Pasquale MD, Civljak R, Kutleša M, Bassetti M, Dimopoulos G, Nava S, Rios F, Zampieri FG, Povoa P, Bos LD, Aliberti S, Torres A, Martín-Loeches I.

ERJ Open Res. 2017 Nov 17;3(4). pii: 00092-2017. doi: 10.1183/23120541.00092-2017. eCollection 2017 Oct.

4.

Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma.

Zannetti BA, Tacchetti P, Pantani L, Gamberi B, Tosi P, Rocchi S, Cellini C, Ronconi S, Pezzi A, Mancuso K, Rizzello I, Caratozzolo I, Martello M, Dozza L, Cavo M, Zamagni E.

Ann Hematol. 2017 Dec;96(12):2071-2078. doi: 10.1007/s00277-017-3140-5. Epub 2017 Oct 24.

PMID:
29063955
5.

Risk of colorectal polyps and of malignancies in asymptomatic carriers of mutations in the main DNA mismatch repair genes.

Ponz de Leon M, Pedroni M, Pezzi A, Sulce B, Roncucci L, Domati F, Rossi G, Reggiani Bonetti L.

Scand J Gastroenterol. 2018 Jan;53(1):31-37. doi: 10.1080/00365521.2017.1386794. Epub 2017 Oct 12.

PMID:
29025352
6.

A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach.

Lanza F, Saraceni F, Pezzi A, Martino M, Bosi A, Cascavilla N, Musto P, Zuffa E, Tani M, Cellini C, Laszlo D, Bonifazi F; GITMO (Italian Society for Transplantation).

Am J Hematol. 2017 Sep;92(9):E557-E559. doi: 10.1002/ajh.24817. Epub 2017 Jul 24. No abstract available.

7.

Effects Of Hypoxia in Long-Term In Vitro Expansion of Human Bone Marrow Derived Mesenchymal Stem Cells.

Pezzi A, Amorin B, Laureano Á, Valim V, Dahmer A, Zambonato B, Sehn F, Wilke I, Bruschi L, Silva MALD, Filippi-Chiela E, Silla L.

J Cell Biochem. 2017 Oct;118(10):3072-3079. doi: 10.1002/jcb.25953. Epub 2017 May 3.

PMID:
28240374
8.

Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells.

Salvestrini V, Orecchioni S, Talarico G, Reggiani F, Mazzetti C, Bertolini F, Orioli E, Adinolfi E, Di Virgilio F, Pezzi A, Cavo M, Lemoli RM, Curti A.

Oncotarget. 2017 Jan 24;8(4):5895-5908. doi: 10.18632/oncotarget.13927.

9.

Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents.

Tacchetti P, Pezzi A, Zamagni E, Pantani L, Rocchi S, Zannetti BA, Mancuso K, Rizzello I, Cavo M.

Haematologica. 2017 Mar;102(3):e104-e107. doi: 10.3324/haematol.2016.154070. Epub 2016 Dec 1. No abstract available.

10.
11.

Attenuated polyposis of the large bowel: a morphologic and molecular approach.

de Leon MP, Pedroni M, Roncucci L, Domati F, Rossi G, Magnani G, Pezzi A, Fante R, Bonetti LR.

Fam Cancer. 2017 Apr;16(2):211-220. doi: 10.1007/s10689-016-9938-9.

PMID:
27783336
12.

Brazilian guidelines on hematopoietic stem cell transplantation in acute myeloid leukemia.

Silla L, Dulley F, Saboya R, Kerbauy F, de Moraes Arantes A, Pezzi A, Gross LG, Paton E, Hamerschlak N.

Eur J Haematol. 2017 Feb;98(2):177-183. doi: 10.1111/ejh.12808. Epub 2016 Oct 11.

PMID:
27621140
13.

Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis.

Martello M, Remondini D, Borsi E, Santacroce B, Procacci M, Pezzi A, Dico FA, Martinelli G, Zamagni E, Tacchetti P, Pantani L, Testoni N, Marzocchi G, Rocchi S, Zannetti BA, Mancuso K, Cavo M, Terragna C.

Leukemia. 2016 Sep;30(9):1869-76. doi: 10.1038/leu.2016.77. Epub 2016 Apr 14.

PMID:
27074969
14.

Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens.

Tacchetti P, Cavo M, Rocchi S, Pezzi A, Pantani L, Brioli A, Testoni N, Terragna C, Zannetti BA, Mancuso K, Marzocchi G, Borsi E, Martello M, Rizzello I, Zamagni E.

Leuk Lymphoma. 2016 Sep;57(9):2058-64. doi: 10.3109/10428194.2015.1124994. Epub 2016 Jan 14.

PMID:
26763357
15.

Tolvaptan for hyponatremia with preserved sodium pool in critically ill patients.

Umbrello M, Mantovani ES, Formenti P, Casiraghi C, Ottolina D, Taverna M, Pezzi A, Mistraletti G, Iapichino G.

Ann Intensive Care. 2016 Dec;6(1):1. doi: 10.1186/s13613-015-0096-2. Epub 2016 Jan 4.

16.

The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD).

Terragna C, Remondini D, Martello M, Zamagni E, Pantani L, Patriarca F, Pezzi A, Levi G, Offidani M, Proserpio I, De Sabbata G, Tacchetti P, Cangialosi C, Ciambelli F, Viganò CV, Dico FA, Santacroce B, Borsi E, Brioli A, Marzocchi G, Castellani G, Martinelli G, Palumbo A, Cavo M.

Oncotarget. 2016 Mar 1;7(9):9666-79. doi: 10.18632/oncotarget.5718.

17.

18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease.

Zamagni E, Nanni C, Gay F, Pezzi A, Patriarca F, Bellò M, Rambaldi I, Tacchetti P, Hillengass J, Gamberi B, Pantani L, Magarotto V, Versari A, Offidani M, Zannetti B, Carobolante F, Balma M, Musto P, Rensi M, Mancuso K, Dimitrakopoulou-Strauss A, Chauviè S, Rocchi S, Fard N, Marzocchi G, Storto G, Ghedini P, Palumbo A, Fanti S, Cavo M.

Leukemia. 2016 Feb;30(2):417-22. doi: 10.1038/leu.2015.291. Epub 2015 Oct 22.

PMID:
26490489
18.

Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma.

Cavo M, Pantani L, Pezzi A, Petrucci MT, Patriarca F, Di Raimondo F, Marzocchi G, Galli M, Montefusco V, Zamagni E, Gamberi B, Tacchetti P, Brioli A, Palumbo A, Sonneveld P.

Leukemia. 2015 Dec;29(12):2429-31. doi: 10.1038/leu.2015.274. Epub 2015 Oct 7. No abstract available.

PMID:
26442610
19.

PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma.

Zamagni E, Nanni C, Mancuso K, Tacchetti P, Pezzi A, Pantani L, Zannetti B, Rambaldi I, Brioli A, Rocchi S, Terragna C, Martello M, Marzocchi G, Borsi E, Rizzello I, Fanti S, Cavo M.

Clin Cancer Res. 2015 Oct 1;21(19):4384-90. doi: 10.1158/1078-0432.CCR-15-0396. Epub 2015 Jun 15.

20.

Diaphragm ultrasound as indicator of respiratory effort in critically ill patients undergoing assisted mechanical ventilation: a pilot clinical study.

Umbrello M, Formenti P, Longhi D, Galimberti A, Piva I, Pezzi A, Mistraletti G, Marini JJ, Iapichino G.

Crit Care. 2015 Apr 13;19:161. doi: 10.1186/s13054-015-0894-9.

21.

Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment.

Zannetti BA, Zamagni E, Santostefano M, De Sanctis LB, Tacchetti P, Mancini E, Pantani L, Brioli A, Rizzo R, Mancuso K, Rocchi S, Pezzi A, Borsi E, Terragna C, Marzocchi G, Santoro A, Cavo M.

Am J Hematol. 2015 Jul;90(7):647-52. doi: 10.1002/ajh.24035.

22.

Importance of early absolute lymphocyte count after allogeneic stem cell transplantation: a retrospective study.

Rigoni L, Scroferneker ML, Pitombeira BS, Ottoni E, Paz A, Fischer G, Michalowski M, Pezzi A, Amorin B, Valim V, Baggio L, Laureano Á, da Silva MA, Silla L, Daudt L.

Transplant Proc. 2015 Mar;47(2):511-6. doi: 10.1016/j.transproceed.2014.11.042.

PMID:
25769599
23.

Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation.

Brioli A, Perrone G, Patriarca F, Pezzi A, Nobile F, Ballerini F, Motta MR, Ronconi S, Tacchetti P, Catalano L, Zannetti BA, Rizzi S, Volpe S, Zamagni E, Liberati AM, Mancuso K, Boccadoro M, Davies FE, Morgan GJ, Palumbo A, Cavo M.

Bone Marrow Transplant. 2015 May;50(5):673-8. doi: 10.1038/bmt.2014.322. Epub 2015 Feb 2.

PMID:
25642764
24.

Hypo-osmolar fluid absorption in endoscopic resection: a new pharmacological approach.

Mantovani E, Pirrone M, Spanu P, Albicini M, Gandola A, Ottolina D, Pezzi A, Iapichino G.

Minerva Anestesiol. 2015 May;81(5):591-2. Epub 2015 Jan 30. No abstract available.

25.

Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study.

Tacchetti P, Terragna C, Galli M, Zamagni E, Petrucci MT, Pezzi A, Montefusco V, Martello M, Tosi P, Baldini L, Peccatori J, Ruggieri M, Pantani L, Lazzaro A, Elice F, Rocchi S, Gozzetti A, Cavaletti G, Palumbo A, Cavo M.

Am J Hematol. 2014 Dec;89(12):1085-91. doi: 10.1002/ajh.23835. Epub 2014 Sep 17.

26.

Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma.

Brioli A, Zannetti BA, Zamagni E, Tacchetti P, Pantani L, Mancuso K, Pezzi A, Rocchi S, Cavo M.

Haematologica. 2014 Nov;99(11):e242-3. doi: 10.3324/haematol.2014.110221. Epub 2014 Aug 1. No abstract available.

27.

Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.

Amorin B, Alegretti AP, Valim V, Pezzi A, Laureano AM, da Silva MA, Wieck A, Silla L.

Hum Cell. 2014 Oct;27(4):137-50. doi: 10.1007/s13577-014-0095-x. Epub 2014 Jun 6. Review.

28.

Combination of international scoring system 3, high lactate dehydrogenase, and t(4;14) and/or del(17p) identifies patients with multiple myeloma (MM) treated with front-line autologous stem-cell transplantation at high risk of early MM progression-related death.

Moreau P, Cavo M, Sonneveld P, Rosinol L, Attal M, Pezzi A, Goldschmidt H, Lahuerta JJ, Marit G, Palumbo A, van der Holt B, Bladé J, Petrucci MT, Neben K, san Miguel J, Patriarca F, Lokhorst H, Zamagni E, Hulin C, Gutierrez N, Facon T, Caillot D, Benboubker L, Harousseau JL, Leleu X, Avet-Loiseau H, Mary JY.

J Clin Oncol. 2014 Jul 10;32(20):2173-80. doi: 10.1200/JCO.2013.53.0329. Epub 2014 Jun 2.

29.

Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma.

Zamagni E, Nanni C, Tacchetti P, Pantani L, Marzocchi G, Zannetti B, Terragna C, Mancuso K, Rocchi S, Pezzi A, Testoni N, Fanti S, Cavo M.

Clin Lymphoma Myeloma Leuk. 2014 Jun;14(3):e101-4. doi: 10.1016/j.clml.2013.12.014. Epub 2013 Dec 26. No abstract available.

PMID:
24508412
30.

Validation of the EBMT Risk Score for South Brazilian Patients Submitted to Allogeneic Hematopoietic Stem Cell Transplantation.

Pitombeira BS, Paz A, Pezzi A, Amorin B, Valim V, Laureano A, Wieck A, Rigoni L, Ottoni E, Fisher G, Daudt L, Silla L.

Bone Marrow Res. 2013;2013:565824. doi: 10.1155/2013/565824. Epub 2013 Dec 12.

31.

Assessment of regulatory T cells in childhood immune thrombocytopenic purpura.

Mazzucco KL, Junior LM, Lemos NE, Wieck A, Pezzi A, Laureano AM, Amorin B, Valim V, Silla L, Daudt LE, Marostica PJ.

ISRN Hematol. 2013 Nov 5;2013:143687. doi: 10.1155/2013/143687. eCollection 2013.

32.

High prevalence of anemia in children and adult women in an urban population in southern Brazil.

Silla LM, Zelmanowicz A, Mito I, Michalowski M, Hellwing T, Shilling MA, Friedrisch JR, Bittar CM, Albrecht CA, Scapinello E, Conti C, Albrecht MA, Baggio L, Pezzi A, Amorin B, Valim V, Fogliatto L, Paz A, Astigarraga C, Bittencourt RI, Fischer G, Daudt L.

PLoS One. 2013 Jul 29;8(7):e68805. doi: 10.1371/journal.pone.0068805. Print 2013.

33.

Detection of minimal residual disease by flow cytometry for patients with multiple myeloma submitted to autologous hematopoietic stem cell transplantation.

Dal Bó S, Pezzi A, Amorin B, Valim V, Isabel Bittencourt R, Silla L.

ISRN Hematol. 2013 Jun 20;2013:847672. doi: 10.1155/2013/847672. Print 2013.

34.

Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes.

Pantani L, Zamagni E, Zannetti BA, Pezzi A, Tacchetti P, Brioli A, Mancuso K, Perrone G, Rocchi S, Tosi P, Cavo M.

Ann Hematol. 2014 Jan;93(1):123-8. doi: 10.1007/s00277-013-1828-8. Epub 2013 Jul 18.

PMID:
23864035
35.

A safety and feasibility study with platelet lysate expanded bone marrow mesenchymal stromal cells for the treatment of acute graft-versus-host disease in Brazil.

Silla L, Valim V, Amorin B, Alegretti AP, Dos Santos de Oliveira F, Lima da Silva MA, Dahmer A, Emerim Lemos N, Mentz Albrecht MA, Macedo Laureano Á, Bonfim C, Moraes Júnior L, Pezzi A, Baggio L, Albrecht CA, Capra M, Fogliatto L, Della Costa Rigoni L, Fischer G, Paz A, Esteves Daudt L.

Leuk Lymphoma. 2014 May;55(5):1203-5. doi: 10.3109/10428194.2013.823495. Epub 2013 Aug 28. No abstract available.

PMID:
23844820
36.

Intensive care of patients requiring open abdomen treatment: a case-series analysis.

Spanu P, Zanforlin G, Noto A, Pezzi A, Marzorati S, Reali-Forster C, Di Mauro P, Bassi G, Oldani S, Destrebecq A, Iapichino G.

Minerva Anestesiol. 2013 Apr;79(4):349-59. Epub 2013 Feb 18.

PMID:
23419332
37.

DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil.

Pezzi A, Moraes L, Valim V, Amorin B, Melchiades G, Oliveira F, da Silva MA, Matte U, Pombo-de-Oliveira MS, Bittencourt R, Daudt L, Silla L.

Adv Hematol. 2012;2012:697691. doi: 10.1155/2012/697691. Epub 2012 Nov 8. Erratum in: Adv Hematol. 2014;2014:148472.

38.

The value of 18F-FDG PET/CT after autologous stem cell transplantation (ASCT) in patients affected by multiple myeloma (MM): experience with 77 patients.

Nanni C, Zamagni E, Celli M, Caroli P, Ambrosini V, Tacchetti P, Brioli A, Zannetti B, Pezzi A, Pantani L, Perrone G, Zompatori M, Cavo M, Colletti PM, Rubello D, Fanti S.

Clin Nucl Med. 2013 Feb;38(2):e74-9. doi: 10.1097/RLU.0b013e318266cee2.

PMID:
23143049
39.

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.

Cavo M, Pantani L, Petrucci MT, Patriarca F, Zamagni E, Donnarumma D, Crippa C, Boccadoro M, Perrone G, Falcone A, Nozzoli C, Zambello R, Masini L, Furlan A, Brioli A, Derudas D, Ballanti S, Dessanti ML, De Stefano V, Carella AM, Marcatti M, Nozza A, Ferrara F, Callea V, Califano C, Pezzi A, Baraldi A, Grasso M, Musto P, Palumbo A; GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network.

Blood. 2012 Jul 5;120(1):9-19. doi: 10.1182/blood-2012-02-408898. Epub 2012 Apr 12.

PMID:
22498745
40.

Direct cost analysis of intensive care unit stay in four European countries: applying a standardized costing methodology.

Tan SS, Bakker J, Hoogendoorn ME, Kapila A, Martin J, Pezzi A, Pittoni G, Spronk PE, Welte R, Hakkaart-van Roijen L.

Value Health. 2012 Jan;15(1):81-6. doi: 10.1016/j.jval.2011.09.007.

41.

The Eldicus prospective, observational study of triage decision making in European intensive care units. Part II: intensive care benefit for the elderly.

Sprung CL, Artigas A, Kesecioglu J, Pezzi A, Wiis J, Pirracchio R, Baras M, Edbrooke DL, Pesenti A, Bakker J, Hargreaves C, Gurman G, Cohen SL, Lippert A, Payen D, Corbella D, Iapichino G.

Crit Care Med. 2012 Jan;40(1):132-8. doi: 10.1097/CCM.0b013e318232d6b0.

PMID:
22001580
42.

The Eldicus prospective, observational study of triage decision making in European intensive care units: part I--European Intensive Care Admission Triage Scores.

Sprung CL, Baras M, Iapichino G, Kesecioglu J, Lippert A, Hargreaves C, Pezzi A, Pirracchio R, Edbrooke DL, Pesenti A, Bakker J, Gurman G, Cohen SL, Wiis J, Payen D, Artigas A.

Crit Care Med. 2012 Jan;40(1):125-31. doi: 10.1097/CCM.0b013e31822e5692.

PMID:
21926598
43.

Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.

Zamagni E, Patriarca F, Nanni C, Zannetti B, Englaro E, Pezzi A, Tacchetti P, Buttignol S, Perrone G, Brioli A, Pantani L, Terragna C, Carobolante F, Baccarani M, Fanin R, Fanti S, Cavo M.

Blood. 2011 Dec 1;118(23):5989-95. doi: 10.1182/blood-2011-06-361386. Epub 2011 Sep 6. Erratum in: Blood. 2012 Sep 13;120(11):2349.

PMID:
21900189
44.

Lymph node micrometastasis and survival of patients with Stage I (Dukes' A) colorectal carcinoma.

Reggiani Bonetti L, Di Gregorio C, De Gaetani C, Pezzi A, Barresi G, Barresi V, Roncucci L, Ponz de Leon M.

Scand J Gastroenterol. 2011 Jul;46(7-8):881-6. doi: 10.3109/00365521.2011.571708. Epub 2011 Apr 15.

PMID:
21492052
45.

Implications of ICU triage decisions on patient mortality: a cost-effectiveness analysis.

Edbrooke DL, Minelli C, Mills GH, Iapichino G, Pezzi A, Corbella D, Jacobs P, Lippert A, Wiis J, Pesenti A, Patroniti N, Pirracchio R, Payen D, Gurman G, Bakker J, Kesecioglu J, Hargreaves C, Cohen SL, Baras M, Artigas A, Sprung CL.

Crit Care. 2011;15(1):R56. doi: 10.1186/cc10029. Epub 2011 Feb 9.

46.

Reasons for refusal of admission to intensive care and impact on mortality.

Iapichino G, Corbella D, Minelli C, Mills GH, Artigas A, Edbooke DL, Pezzi A, Kesecioglu J, Patroniti N, Baras M, Sprung CL.

Intensive Care Med. 2010 Oct;36(10):1772-9. doi: 10.1007/s00134-010-1933-2. Epub 2010 Jun 9.

PMID:
20533023
47.

Interferon-gamma-release assays detect recent tuberculosis re-infection in elderly contacts.

Ferrara G, Losi M, D'Amico R, Cagarelli R, Pezzi AM, Meacci M, Meccugni B, Marchetti Dori I, Rumpianesi F, Roversi P, Casali L, Fabbri LM, Richeldi L.

Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3):669-77.

PMID:
19822083
48.

Clinical features and colorectal cancer survival: an attempt to explain differences between two different Italian regions.

Fusco M, Pezzi A, Benatti P, Roncucci L, Chiodini P, Di Maio G, Di Napoli R, de Leon MP.

Eur J Cancer. 2010 Jan;46(1):142-9. doi: 10.1016/j.ejca.2009.07.005.

PMID:
19695865
49.

Effect of betamethasone on the pulp after topical application to the dentin of rat teeth: vascular aspects of the inflammation.

Fachin EV, Scarparo RK, Pezzi AP, Luisi SB, Sant'ana Filho M.

J Appl Oral Sci. 2009 Jul-Aug;17(4):335-9.

50.

Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis.

Pezzi A, Roncucci L, Benatti P, Sassatelli R, Varesco L, Di Gregorio C, Venesio T, Pedroni M, Maffei S, Reggiani Bonetti L, Borsi E, Ferrari M, Martella P, Rossi G, Ponz De Leon M.

Scand J Gastroenterol. 2009;44(9):1092-100. doi: 10.1080/00365520903100481.

PMID:
19593690

Supplemental Content

Support Center